Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.32 +0.01 (+3.91%)
At close: Oct 1, 2026 · 4:00 PM EDT

Senti Biosciences Holdings (SNTI) Current Deferred Revenue (2021 - 2026)

Updated

Senti Biosciences Holdings (SNTI) reported Current Deferred Revenue of $11,000 for Q2 2026.

Analysis

Senti Biosciences Holdings (SNTI) Current Deferred Revenue (2021 - 2026) Analysis & Trends

At the end of FY2025, Senti Biosciences Holdings posted Current Deferred Revenue of $43,000.

  • Current Deferred Revenue has a four-year compound annual growth rate of -59.9% (FY2021 to FY2025).
  • By year, Current Deferred Revenue came in at $799,000 in FY2022 (-51.8%) and $1.66 million in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Current Deferred Revenue in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Senti Biosciences Holdings 9.65 Mn 9.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11,000.00
Dec 31, 2025 43,000.00
Jun 30, 2023 164,000.00
Mar 31, 2023 407,000.00
Dec 31, 2022 799,000.00
Sep 30, 2022 99,000.00
Jun 30, 2022 833,000.00
Dec 31, 2021 1.66 Mn
API Access

Senti Biosciences Holdings Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=SNTI&period=max&api_key=YOUR_API_KEY